A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma

Haematologica · Published 2026-07-23 · DOI 10.3324/haematol.2026.300656

Free full text

Authors (27)

Urvi A. Shah, Andriy Derkach, Meghana Pagadala, Kelly Barnett, Sean Devlin, Sham Mailankody, Neha Korde, Malin Hultcrantz, Carlyn Tan, Francesco Maura, Kylee Maclachlan, Gunjan L. Shah, Michael Scordo, Parastoo B. Dahi, Heather J. Landau, Hani Hassoun, Oscar B. Lahoud, Ola Landgren, Jonathan Landa, Bernard O’Malley, Sergio Giralt, Brandon S. Imber, Christopher A. Barker, Saad Z. Usmani, Taha Merghoub, Joachim Yahalom, Alexander M. Lesokhin

Abstract

Not available.

Abstract from DOAJ. Public domain (CC0 1.0).

Read the article at the publisher →

Publication details

Year

2026

Citation

Shah, U., Derkach, A., Pagadala, M., et al. (2026). A pilot trial evaluating lenalidomide and oral azacitidine with radiotherapy for patients with newly diagnosed and relapsed plasmacytoma. Haematologica. https://doi.org/10.3324/haematol.2026.300656

Related articles

• Daratumumab combining with venetoclax, three-day multi-frequency decitabine, vincristine, dexamethasone (VDVD) as the salvage treatment of relapsed/refractory T-cell acute lymphoblastic leukemia · Haematologica · 2026 · Same journal
• Comparison and combination of prognostic scores for nodular lymphocytepredominant Hodgkin lymphoma: an analysis from the German Hodgkin Study Group · Haematologica · 2026 · Same journal
• Risk factors and their contributions to prognosis in multiple myeloma · Haematologica · 2026 · Same journal
• Risks and benefits of gene therapy and transplantation in sickle cell disease. Comment on: ,HLA-haploidentical hematopoietic stem cell transplantation in patients with sickle cell disease: results from the phase II DREP-HAPLO trial- · Haematologica · 2026 · Same journal
• Connecting asciminib tolerability to long-term treatment persistence. Comment on: "Favorable tolerability of asciminib versus ATP-competitive tyrosine kinase inhibitors in the ASC4FIRST study of newly diagnosed patients with chronic-phase chronic myeloid leukemia" · Haematologica · 2026 · Same journal
• Enteropathy-associated T-cell lymphoma: molecular clonal evolution and its clinical consequences · Haematologica · 2026 · Same journal
• Genetic screening alters diagnosis and management in patients with immune thrombocytopenia · Haematologica · 2026 · Same journal
• Mechanisms of blood-induced joint disease in hemophilia and potential novel targets for interventions · Haematologica · 2026 · Same journal
• Safety, feasibility, and efficacy of anti-PD-1 therapy for the treatment of classical Hodgkin lymphoma · Haematologica · 2026 · Same journal
• Characteristics of clonal cytopenia of undetermined significance in the presence of ZRSR2 mutations · Haematologica · 2026 · Same journal